- Published at
- by marijuanastocks.com
positive
positive
News for Neptune Wellness Solutions Inc. (NTU.F)
- Published at
- by marijuanastocks.com
mixedmixedNeptune Wellness Solutions Inc. (NEPT) President Michael Cammarata Named Top 25 Biotech CEO
Neptune Wellness Solutions Inc. President Michael Cammarata Named Top 25 Biotech CEO Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASD...- Published at
- by marijuanastocks.com
mixedmixed- Published at
- by marijuanastocks.com
positivepositiveNeptune Wellness Solutions Inc. (NEPT) Finds Patented Maxsimil® Fish Oil Up to 3.5 Times More Absorbable Than Standard Fish Oil
Groundbreaking Research Finds Neptune’s Patented Maxsimil® Fish Oil Up to 3.5 Times More Absorbable Than Standard Fish Oil Neptune Wellness Solutions Inc. (...- Published at
- by prnewswire.com
positivepositiveMood Ring™, by Neptune Wellness Solutions Inc., Now Available in Ontario
/PRNewswire/ - Neptune Wellness Solutions, Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness...- Published at
- by benzinga.com
mixedmixedBougainville Ventures (BUGVF), Christina Lake Cannabis (CLCFF), Fire & Flower Holdings (FFLWF), GW Pharma (GWPH), LIQUOR STORES NA (LQSIF), INDIVA LTD by Indiva Ltd. (NDVAF), Neptune Technologies & Bi
Despite several big news items out of the industry this week, cannabis stocks posted mixed performances. Over the last five trading days ...- Published at
- by marijuanastocks.com
positivepositiveNeptune Wellness Solutions, Inc. (NEPT) Announces Termination of “At-The-Market” Offering
Neptune Wellness Solutions Inc. Announces Termination of “At-The-Market” Offering Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NA...- Published at
- by rttnews.com
mixedmixedBLUE Hit By SCD Trial Blues, CRTX Plunges On Partial Hold, SESN To Face FDA In August
Today's Daily Dose brings you news about temporary suspension of bluebird bio's gene therapy trials in sickle cell disease, Sesen Bio's regulatory catalyst for this year, partial hold on Cortexyme's open-label extension phase of its ongoing phase II/III study of Atuzaginstat for Alzheimer's disease, and expanded FDA approval of Novartis' Entresto.- Published at
- by markets.businessinsider.com
mixedmixedBLUE Hit By SCD Trial Blues, CRTX Plunges On Partial Hold, SESN To Face FDA In August
(RTTNews) - Today's Daily Dose brings you news about temporary suspension of bluebird bio's gene therapy trials in sickle cell disease, Sesen Bio'...- Published at
- by benzinga.com
mixedmixedMid-Afternoon Market Update: Crude Oil Rise; Energy Shares Continue To Climb
Toward the end of trading Tuesday, the Dow traded up 0.34% to 31,564.92 while the NASDAQ fell 0.19% to 14,068.89. The S&P gained 0.11% to ...- Published at
- by seekingalpha.com
neutralneutralNeptune Wellness Solutions Inc. (NEPT) CEO Michael Cammarata on Q3 2020 Results - Earnings Call Transcript
Neptune Wellness Solutions Inc. (NASDAQ:NEPT) Q3 2020 Earnings Conference Call February 16, 2021 08:30 AM ET Company Participants Michael Cammarata - President & Chief Executive Officer...